Back
Lody Andrian Info Index
Category
Research & Strategy
Client
Novo Nordisk, Is It A Bird
Year
2018

Service design for diabetes care in Indonesia

Category
Research & Strategy
Client
Novo Nordisk, Is It A Bird
Year
2018

Novo Nordisk makes insulin. The company wanted to understand why diabetes care still fails so many patients in Indonesia, a market its working model of the patient did not fit. That model was built elsewhere: a person who reasons about illness biomedically, reaches a clinic without friction, and manages the disease through nutrition. Indonesia broke each assumption. The real problem was the distance between an abstract patient and a situated one.

Research with doctors, caregivers, and patients across class lines, together with firsthand observation inside the hospitals, located the obstacle, and it was rarely the medicine. Obtaining insulin through the national insurance scheme meant a day-long bureaucratic procession that reset whenever a document, a fasting requirement, or a lab result went missing. Consultations happened behind curtains, where patients overheard one another, the scoldings included. The disease was understood through a folk distinction between wet diabetes and dry that drifted from clinical fact. Food was cheap, sweet, and class-bound, and eating well was understood as eating less, when it needed to mean eating differently.

A findings deck would have flattened all of this. The work was delivered instead as a zine and a small exhibition staged in Copenhagen, which set the client down inside the patient’s day. The recommendations that followed worked on service and education, the world around the molecule.

The insulin did its job. For a chronic disease, the real burden sits in everything a patient must endure to reach it, and everything they believe before they begin.

Placeholder
Placeholder